Minerva Surgical, Inc. (UTRS)
OTCMKTS: UTRS · Delayed Price · USD
0.410
0.00 (0.00%)
Apr 24, 2024, 10:32 AM EDT - Market open
Minerva Surgical Stock Forecast
UTRS's stock price has decreased by -91.63% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Minerva Surgical stock has a target of 20, which predicts an increase of 4,778.05% from the current stock price of 0.41.
Analyst Consensus: Buy
* Price targets were last updated on May 3, 2023.
Analyst Ratings
According to 1 stock analyst, the rating for UTRS is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '22 | Jan '23 | Feb '23 | Mar '23 | Apr '23 | May '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $100 → $20 | Buy | Maintains | $100 → $20 | +4,778.05% | May 3, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $120 → $100 | Buy | Maintains | $120 → $100 | +24,290.24% | Aug 10, 2022 |
| JP Morgan | JP Morgan | Buy → Sell Downgrades n/a | Buy → Sell | Downgrades | n/a | n/a | Aug 10, 2022 |
| Piper Sandler | Piper Sandler | Buy Maintains $240 → $120 | Buy | Maintains | $240 → $120 | +29,168.29% | May 12, 2022 |
| SVB Leerink | SVB Leerink | Buy Maintains $160 → $140 | Buy | Maintains | $160 → $140 | +34,046.34% | May 12, 2022 |
Financial Forecast
Revenue This Year
52.84M
from 50.29M
Increased by 5.05%
Revenue Next Year
60.79M
from 52.84M
Increased by 15.06%
EPS This Year
-4.15
from -23.68
EPS Next Year
-2.95
from -4.15
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | 54.4M | 62.6M | 71.9M |
| Avg | 52.8M | 60.8M | 69.9M |
| Low | 50.8M | 58.4M | 67.1M |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | 8.1% | 18.4% | 18.3% |
| Avg | 5.1% | 15.1% | 14.9% |
| Low | 0.9% | 10.5% | 10.4% |
EPS Forecast
| EPS | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | -4.27 | -3.03 | -2.94 |
| Avg | -4.15 | -2.95 | -2.86 |
| Low | -3.99 | -2.83 | -2.74 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.